New Biologic Therapies Showing Promise In A Variety Of Advanced Solid Tumors
Two Groups Take Different Approaches To Toxicity Of Saltz Regimen In Studies
Zevalin Regimen Better Than Rituximab Alone For NHL
SWOG Trial Reports Longest Survival To Date For NSCLC
Two Drugs Slow Progress Of Metastatic Prostate Cancer
New Ultrasound Technique For Hard To Diagnose Cysts
NCI-Approved Clinical Trials Listed For May 2001
Trending Stories
- Knight Cancer Institute receives record-setting $2B gift from the Knights—and self-governance within OHSU
Brian Druker returns to executive role as president of the new Knight Cancer Group - Banished from the institute he founded, separated from his lab materials, Tom Curran sues Children’s Mercy
Whistleblower lawsuit alleges wrongful firing - ACOG says it will no longer accept federal funding
- Lou Weiner: Poetry and art help us imagine my mother’s world as a hidden child of the Holocaust
- When public service ends abruptly, do books provide solace? An escape? Perspective?
Former NIH and FDA employees tell us what they are reading in 2025 - All federal grants must be reviewed by Trump appointees, executive order directs